Stock Scorecard
Stock Summary for Creative Medical Technology Holdings Inc (CELZ) - $2.14 as of 5/9/2025 8:15:48 PM EST
Total Score
11 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CELZ
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CELZ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CELZ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CELZ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CELZ (27 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 2 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CELZ
Financial Details for CELZ
Company Overview |
|
|---|---|
| Ticker | CELZ |
| Company Name | Creative Medical Technology Holdings Inc |
| Country | USA |
| Description | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 2.14 |
| Price 4 Years Ago | 22.10 |
| Last Day Price Updated | 5/9/2025 8:15:48 PM EST |
| Last Day Volume | 35,047 |
| Average Daily Volume | 74,196 |
| 52-Week High | 6.90 |
| 52-Week Low | 1.69 |
| Last Price to 52 Week Low | 26.63% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 41.93 |
| Sector PE | 45.26 |
| 5-Year Average PE | -1.01 |
| Free Cash Flow Ratio | 0.93 |
| Industry Free Cash Flow Ratio | 18.81 |
| Sector Free Cash Flow Ratio | 29.93 |
| Current Ratio Most Recent Quarter | 18.73 |
| Total Cash Per Share | 2.30 |
| Book Value Per Share Most Recent Quarter | 3.63 |
| Price to Book Ratio | 0.81 |
| Industry Price to Book Ratio | 9.51 |
| Sector Price to Book Ratio | 21.41 |
| Price to Sales Ratio Twelve Trailing Months | 467.75 |
| Industry Price to Sales Ratio Twelve Trailing Months | 47.13 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.24 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 2,585,500 |
| Market Capitalization | 5,532,970 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 358.90% |
| Annual Earnings Growth | -3.91% |
| Reported EPS 12 Trailing Months | -3.71 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -3.71 |
| Net Income Twelve Trailing Months | -6,306,011 |
| Net Income Past Year | -5,493,481 |
| Net Income Prior Year | -5,286,574 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | -41.85% |
| Operating Margin Twelve Trailing Months | -62,858.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 5,940,402 |
| Total Cash Past Year | 5,940,402 |
| Total Cash Prior Year | 3,466,867 |
| Net Cash Position Most Recent Quarter | 5,940,402 |
| Net Cash Position Past Year | 5,940,402 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 697,602 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 6,341,499 |
| Total Stockholder Equity Prior Year | 10,343,796 |
| Total Stockholder Equity Most Recent Quarter | 6,341,499 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -6,353,972 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.46 |
| Free Cash Flow Past Year | -5,501,292 |
| Free Cash Flow Prior Year | -8,127,884 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.15 |
| MACD Signal | -0.21 |
| 20-Day Bollinger Lower Band | 0.80 |
| 20-Day Bollinger Middle Band | 2.96 |
| 20-Day Bollinger Upper Band | 5.13 |
| Beta | 4.85 |
| RSI | 47.61 |
| 50-Day SMA | 4.56 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 17.29 |
System |
|
| Modified | 5/9/2025 8:15:50 PM EST |